Carrivick Simon J, Walsh John P, Brown Suzanne J, Wardrop Robert, Hadlow Narelle C
Department of Clinical Biochemistry (S.J.C., R.W., N.C.H.), PathWest Laboratory Medicine, Queen Elizabeth II Medical Centre, Nedlands, Western Australia 6009, Australia; Department of Endocrinology and Diabetes (S.J.C., J.P.W., S.J.B.), Sir Charles Gairdner Hospital, Nedlands, Western Australia 6009, Australia; and School of Medicine and Pharmacology (J.P.W.) and School of Pathology and Laboratory Medicine (N.C.H.), The University of Western Australia, Crawley, Western Australia 6009, Australia.
J Clin Endocrinol Metab. 2015 May;100(5):2131-4. doi: 10.1210/jc.2014-4370. Epub 2015 Mar 9.
Circulating PTH concentrations increase with age. It is uncertain whether an age-related PTH increase occurs independent of changes in circulating 25-hydroxyvitamin D, phosphate, renal function, and ionized calcium.
The purpose of this article was to analyze the relationship between PTH and age, controlling for 25-hydroxyvitamin D, phosphate, renal function, and ionized calcium.
This was a retrospective, cross-sectional study analyzing the relationship between PTH and age in 2 independent datasets (laboratory 1, n = 17 275 and laboratory 2, n = 4878). We further analyzed subgroups after excluding participants with estimated glomerular filtration rate of <60 mL/min/1.73 m(2) or 25-hydroxyvitamin D of <50 nmol/L (for subgroups, n = 12 051 for laboratory 1 and 3473 for laboratory 2).
After adjustment for sex, ionized calcium, 25-hydroxyvitamin D, phosphate, and estimated glomerular filtration rate, each 10-year increase in age was associated with a 5.0% increase in PTH (95% confidence interval [CI], 4.4%-5.6%; P < .001) in laboratory 1 and a 4.2% increase in laboratory 2 (95% CI, 3.0%-5.4%; P < .001). In the subgroups, each 10-year increase in age was associated with a 6.1% increase in PTH (95% CI, 5.5%-6.8%; P < .001) in laboratory 1 and a 4.9% increase (95% CI 3.5%-6.2%; P < .001) in laboratory 2.
PTH concentrations increase with age, independent of 25-hydroxyvitamin D, ionized calcium, phosphate, and renal function. Further research is required to explore the underlying mechanisms and clinical relevance and to determine whether the use of age-related PTH reference ranges improves diagnostic accuracy, particularly in elderly individuals.
循环中甲状旁腺激素(PTH)浓度随年龄增长而升高。目前尚不确定与年龄相关的PTH升高是否独立于循环中25-羟维生素D、磷酸盐、肾功能和离子钙的变化而发生。
本文旨在分析PTH与年龄之间的关系,并对25-羟维生素D、磷酸盐、肾功能和离子钙进行校正。
这是一项回顾性横断面研究,分析了2个独立数据集(实验室1,n = 17275;实验室2,n = 4878)中PTH与年龄之间的关系。我们在排除估算肾小球滤过率<60 mL/min/1.73 m²或25-羟维生素D<50 nmol/L的参与者后,进一步分析了亚组(实验室1亚组n = 12051,实验室2亚组n = 3473)。
在对性别、离子钙、25-羟维生素D、磷酸盐和估算肾小球滤过率进行校正后,在实验室1中,年龄每增加10岁,PTH升高5.0%(95%置信区间[CI],4.4%-5.6%;P <.001),在实验室2中升高4.2%(95% CI,3.0%-5.4%;P <.001)。在亚组中,实验室1中年龄每增加10岁,PTH升高6.1%(95% CI,5.5%-6.8%;P <.001),实验室2中升高4.9%(95% CI 3.5%-6.2%;P <.001)。
PTH浓度随年龄增长而升高,独立于25-羟维生素D、离子钙、磷酸盐和肾功能。需要进一步研究以探索其潜在机制和临床相关性,并确定使用与年龄相关的PTH参考范围是否能提高诊断准确性,尤其是在老年人中。